Considerations for clinical trial design and data analyses of thorough QT studies using drug-drug interaction
J Clin Pharmacol
.
2010 Oct;50(10):1106-11.
doi: 10.1177/0091270009358710.
Epub 2010 May 10.
Authors
Hao Zhu
1
,
Yaning Wang
,
Jogarao V Gobburu
,
Christine E Garnett
Affiliation
1
Division of Pharmacometrics, Office of Clinical Pharmacology, CDER, Food and Drug Administration, 10903 New Hampshire Avenue, Room 3150, Building 51, Silver Spring 20993, USA.
[email protected]
PMID:
20457587
DOI:
10.1177/0091270009358710
No abstract available
MeSH terms
Clinical Trials as Topic / methods
Drug Interactions
Drug-Related Side Effects and Adverse Reactions*
Humans
Long QT Syndrome / chemically induced*